Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Urethral Neoplasms × pegfilgrastim × 30 days × Clear all

Sponsor

Conditions

Hodgkin Disease 2 Teratoma 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Osteosarcoma 1 Leukemia, Myeloid, Acute 1 Infiltrating Bladder Urothelial Carcinoma 1 Desmoplastic Small Round Cell Tumor 1 Choriocarcinoma 1 Carcinoma, Embryonal 1 Burkitt Lymphoma 1 Breast Neoplasms 1

Interventions

Specimen Handling 5 Magnetic Resonance Spectroscopy 4 cabozantinib 3 Nivolumab 3 Ipilimumab 3 CTLA-4 Antigen 3 avelumab 2 Immunoglobulin G 2 Disulfides 2 Biopsy 2 tremelimumab 1 trastuzumab deruxtecan 1 tocilizumab 1 eribulin 1 erdafitinib 1 enfortumab vedotin 1 durvalumab 1 atezolizumab 1 Contrast Media 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡